Cardiac Arrest Following an Iatrogenic 3, 4-Diaminopyridine Intoxication in a Patient with Lambert-Eaton Myasthenic Syndrome
Authors:
- 1 January 1995
- journal article
- case report
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 33 (3) , 249-251
Abstract
Syndromes with impaired neuromuscular transmission are frequently treated with pyridine derivates. 3,4-diaminopyridine is thought to have fewer side effects than the commonly used, but less potent, 4-aminopyridine. We describe a patient with an initially unrecognized iatrogenic intoxication with 3,4-diaminopyridine. Except for a life threatening arrhythmia, symptoms were similar to a 4-aminopyridine intoxication. The patient made a full recovery with symptomatic treatment and withdrawal of the drug.Keywords
This publication has 5 references indexed in Scilit:
- 3,4-Diaminopyridine in the Treatment of Lambert–Eaton Myasthenic SyndromeNew England Journal of Medicine, 1989
- Evaluation of 4-aminopyridine and 3,4-diaminopyridine penetrability into cerebrospinal fluid in anesthetized ratsBrain Research, 1984
- Treatment with oral 4‐aminopyridine in disorders of neuromuscular transmissionNeurology, 1981
- Potency of 3,4-Diaminopyridine and 4-aminopyridine on mammalian neuromuscular transmission and the effect of pH changesEuropean Journal of Pharmacology, 1980
- Poisoning with 4-Aminopyridine: Report of Three CasesClinical Toxicology, 1980